₹846.15
▼ -8.63 -1.01%
11 Sept 2026
BSE Listed · Pharmaceuticals
Albert David Ltd. (524075)
Volume: 88Avg Vol 1W: 167Avg Vol 1M: 55252W Range:₹581.3₹925
Key Ratios
Checked just nowMarket Cap₹483 Cr
Current Price₹846.15
Previous Close₹854.78
High / Low (52w)₹925 / ₹581.3
Volume88
Avg Vol (1W)167
Avg Vol (1M)552
Stock P/E21.41
Book Value₹685.71
Dividend Yield58%
ROE-38.18%
ROA434.77%
Revenue (TTM)—
Revenue Growth—
Profit Margin6.19%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹39.52
P/B1.23
Debt / Equity0.05
50 DMA₹774.63
200 DMA₹732.63
Day change-1.01%
Price Chart
₹846.15▲ 5.29% · 1Y
2025-09-112026-09-11
20-day avg volume: 542 shares
Pros
- Pays a dividend yield of 58.0%.
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹98 Cr | ₹83 Cr | ₹75 Cr | ₹71 Cr | ₹87 Cr | ₹90 Cr | ₹86 Cr | ₹101 Cr |
| EBITDA | ₹25 Cr | ₹-10 Cr | ₹-12 Cr | ₹9 Cr | ₹-2 Cr | ₹21 Cr | ₹-25 Cr | ₹36 Cr |
| Net Profit | ₹18 Cr | ₹-9 Cr | ₹-10 Cr | ₹8 Cr | ₹-3 Cr | ₹15 Cr | ₹-21 Cr | ₹32 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹324 Cr | ₹328 Cr | ₹265 Cr | ₹329 Cr | ₹357 Cr | ₹420 Cr | ₹375 Cr | ₹341 Cr |
| EBITDA | ₹29 Cr | ₹30 Cr | ₹28 Cr | ₹48 Cr | ₹51 Cr | ₹98 Cr | ₹26 Cr | ₹3 Cr |
| Net Profit | ₹27 Cr | ₹19 Cr | ₹22 Cr | ₹35 Cr | ₹36 Cr | ₹75 Cr | ₹17 Cr | ₹-1 Cr |
| EPS | 46.68 | 33.59 | 38.8 | 61.78 | 63.39 | 132.15 | 30.14 | -2.62 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹295 Cr | ₹320 Cr | ₹341 Cr | ₹401 Cr | ₹423 Cr | ₹498 Cr | ₹511 Cr | ₹519 Cr |
| Total Liabilities | ₹84 Cr | ₹97 Cr | ₹97 Cr | ₹122 Cr | ₹112 Cr | ₹115 Cr | ₹119 Cr | ₹128 Cr |
| Equity | ₹210 Cr | ₹223 Cr | ₹244 Cr | ₹279 Cr | ₹312 Cr | ₹383 Cr | ₹392 Cr | ₹392 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹39 Cr | ₹53 Cr | ₹26 Cr | ₹62 Cr | ₹-20 Cr | ₹-3 Cr |
| Investing | ₹-39 Cr | ₹-40 Cr | ₹-5 Cr | ₹-33 Cr | ₹23 Cr | ₹-4 Cr |
| Financing | ₹-2 Cr | ₹-2 Cr | ₹-6 Cr | ₹-8 Cr | ₹0 Cr | ₹12 Cr |
| Free Cash Flow | ₹39 Cr | ₹53 Cr | ₹26 Cr | ₹62 Cr | ₹-20 Cr | ₹-3 Cr |
Shareholding
Promoter 62.24% Institutions 2.2% Public 35.56%
Efficiency & Working Capital
ROCE0.7%
Interest Coverage1.2
Dividend Payout—
Debtor Days37 d
Inventory Days64 d
Payable Days36 d
Cash Conversion Cycle65 d
Working Capital Days101 d
Shareholding Details
As of 2026-06-30
Promoter62.2%
FII0.6%
DII1.6%
Institutions2.2%
Public35.6%
Promoter Pledge0%
No. of Shareholders13,155
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62% | 62% | 62.1% | 62.1% | 62.1% | 62.1% | 62.2% | 62.2% | 62.2% | 62.2% | 62.2% | 62.2% |
| FIIs | 0.6% | 0.7% | 1% | 0.8% | 0.9% | 0.9% | 1% | 0.8% | 0.6% | 0.6% | 0.6% | 0.6% |
| DIIs | 1.9% | 1.7% | 1.7% | 1.7% | 1.6% | 1.6% | 1.6% | 1.7% | 1.7% | 1.7% | 1.7% | 1.6% |
| Public | 35.5% | 35.6% | 35.2% | 35.4% | 35.3% | 35.4% | 35.1% | 35.3% | 35.5% | 35.5% | 35.5% | 35.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9,907 | 10,041 | 11,266 | 12,349 | 13,590 | 14,830 | 15,304 | 15,070 | 14,666 | 13,967 | 13,555 | 13,155 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kothari Investment And Industries Private Limited | Shareholding of Promoter and Promoter Group | 41.4% | 23,60,531 |
| Anand Vardhan Kothari | Shareholding of Promoter and Promoter Group | 9.9% | 5,66,500 |
| M D Kothari And Company Limited | Shareholding of Promoter and Promoter Group | 6.9% | 3,94,700 |
| Kothari Phytochemicals & Industries Limited | Shareholding of Promoter and Promoter Group | 1.7% | 99,200 |
| Arun Kumar Kothari | Shareholding of Promoter and Promoter Group | 1.7% | 97,000 |
| General Insurance Corporation Of India | Public Shareholding | 1.6% | 91,850 |
| Vikabh Securities Pvt. Ltd. | Public Shareholding | 1% | 57,250 |
| Prabhawati Devi Kothari | Shareholding of Promoter and Promoter Group | 0.3% | 17,527 |
| Paramsukhdas Suganchand Huf (karta - Arun Kumar Kothari) | Shareholding of Promoter and Promoter Group | 0.3% | 15,000 |
| Vedika Kothari | Shareholding of Promoter and Promoter Group | 0% | 1,500 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| A K Kothari | Chairman & Exec. Director | 2026 |
| P D Kothari | Non Executive Director | 2026 |
| Anand Vardhan Kothari | Non Executive Director | 2026 |
| Shourya Sengupta | Independent Non Exe. Director | 2026 |
| Monjori Mitra | Independent Non Exe. Director | 2026 |
| ANURAG SINGHI | Independent Non Exe. Director | 2026 |
| NARESH PACHISIA | Independent Non Exe. Director | 2026 |
| Rajiv Anant Desai | Independent Non Exe. Director | 2026 |
| Amit Mahla | Whole Time Director & CEO | 2026 |
| LALIT LOHIA | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing of pharmaceutical pro | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 10 | 6 | 6 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-06 | Board Meetings | — |
| forthcoming | 2026-07-30 | Dividend (5/- per share) | Final |
| dividend | 2026-07-30 | ₹5 (50%) | Final |
| dividend | 2025-07-25 | ₹5 (50%) | Final |
| forthcoming | — | Book Closure | AGM & 50% Final Dividend |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 4 | 3 | 7 |
| 2026 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2026 | 0 | 0 | 0 | 4 | 2 | 6 |
Insider / Designated-Person Trades
23 recent disclosure(s)
KOTHARI PHYTOCHEMICALS & INDUSTRIES LIMITEDAcquisition · 6,000
Kothari Phytochemicals & Industries LimitedAcquisition · 2,700
Kothari Investment & Industries Private LimitedAcquisition · 2,300
M D Kothari & Company LtdAcquisition · 1,006
Kothari Investment & Industires Private LimitedAcquisition · 2,000
Anand Vardhan KothariAcquisition · 1,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market18/02/2025 - 24/02/2025 · 6,000
Company Information
Incorporated1938
ChairmanA K Kothari
AuditorL B Jha & Co
Investor Email[email protected]; [email protected]
📍 D Block 3rd Flr Gillander Hous, Netaji Subhas Road, Kolkata, West Bengal, 700001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search